None
Quote | AmpliPhi Biosciences Corporation (NYSE:APHB)
Last: | $ |
---|---|
Change Percent: | -20.33% |
Open: | $0.347 |
Close: | $0.3179 |
High: | $0.359 |
Low: | $0.3086 |
Volume: | 4,538,981 |
Last Trade Date Time: | 12/31/1969 07:00:00 pm |
News | AmpliPhi Biosciences Corporation (NYSE:APHB)
AmpliPhi Biosciences Corporation (NYSE American: APHB) , a clinical-stage biotechnology company focused on precisely targeted bacteriophage therapeutics for antibiotic-resistant infections, today announced that its stockholders voted to approve the proposals required to complete the busines...
AmpliPhi Biosciences (NYSEMKT: APHB ): Q1 GAAP EPS of -$0.11 in-line. More news on: AmpliPhi Biosciences Corporation, Earnings news and commentary, Healthcare stocks news, , Read more ...
Message Board Posts | AmpliPhi Biosciences Corporation (NYSE:APHB)
Subject | By | Source | When |
---|---|---|---|
No posts yet. |
News, Short Squeeze, Breakout and More Instantly...
AmpliPhi Biosciences Corporation Company Name:
APHB Stock Symbol:
NYSE Market:
AmpliPhi Biosciences Corporation (NYSE American: APHB) , a clinical-stage biotechnology company focused on precisely targeted bacteriophage therapeutics for antibiotic-resistant infections, today announced that its stockholders voted to approve the proposals required to complete the busines...
Entered into a merger agreement with C3J Therapeutics that is expected to result in an NYSE American-listed company (to be named Armata Pharmaceuticals) focused on development of precisely targeted bacteriophage therapeutics $10.0 million of new capital to be invested in combined co...
Entered into a merger agreement with C3J Therapeutics that is expected to result in an NYSE American-listed company focused on development of precisely-targeted bacteriophage therapeutics $10.0 million of new capital will be invested in combined company to be re-named Armata Pharmac...